Brief: Phio Pharmaceuticals Posts Q3 Loss Per Share Of $0.28
10/11/2021 23:28
Nov 10 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q3 LOSS PER SHARE $0.28
* EXPECTS ITS CURRENT CASH WILL BE SUFFICIENT TO FUND
CURRENTLY
PLANNED OPERATIONS TO Q2 OF 2023
Source text for Eikon: ID:nPnb6RXg9a
Further company coverage: PHIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing